SUMATRIPTAN INJECTION, USP
DR REDDY'S LABORATORIES LTD
Quick answers
Is there a shortage of SUMATRIPTAN INJECTION, USP in Canada?
No. There is no current shortage of SUMATRIPTAN INJECTION, USP 6MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IMITREX
GLAXOSMITHKLINE INC
TARO-SUMATRIPTAN
TARO PHARMACEUTICALS INC
Other Products
IMITREX DF - TAB 100MG
GLAXOSMITHKLINE INC
MYLAN-SUMATRIPTAN
MYLAN PHARMACEUTICALS ULC
TEVA-SUMATRIPTAN
TEVA CANADA LIMITED
TEVA-SUMATRIPTAN DF
TEVA CANADA LIMITED
DIN
02532387
Strength
6MG
Dosage Form
Solution
Route
Subcutaneous
Active Ingredient
SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
See all SUMATRIPTAN (SUMATRIPTAN SUCCINATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from DR REDDY'S LABORATORIES LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02462826
3.5MG · DIN 02452456
2.5MG · DIN 02550075
40MG · DIN 02495635
250MCG · DIN 02530430
500MG · DIN 02490463
0.5MG · DIN 02545950
1G · DIN 02511150
7.5MG · DIN 02406896
2.5MG · DIN 02406853
5MG · DIN 02458403
500MG · DIN 02463091